Canada · Delayed Price · Currency is CAD Kits Eyecare Statistics
Total Valuation
Kits Eyecare has a market cap or net worth of CAD 568.25 million. The enterprise value is 555.77 million.
| Market Cap | 568.25M |
| Enterprise Value | 555.77M |
Important Dates
The next estimated earnings date is Wednesday, March 4, 2026.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kits Eyecare has 32.14 million shares outstanding. The number of shares has increased by 7.93% in one year.
| Current Share Class | 32.14M |
| Shares Outstanding | 32.14M |
| Shares Change (YoY) | +7.93% |
| Shares Change (QoQ) | +6.76% |
| Owned by Insiders (%) | 27.63% |
| Owned by Institutions (%) | 14.18% |
| Float | 12.76M |
Valuation Ratios
The trailing PE ratio is 110.80 and the forward PE ratio is 70.95.
| PE Ratio | 110.80 |
| Forward PE | 70.95 |
| PS Ratio | 2.94 |
| PB Ratio | 9.17 |
| P/TBV Ratio | 27.04 |
| P/FCF Ratio | 74.90 |
| P/OCF Ratio | 64.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 51.89, with an EV/FCF ratio of 73.25.
| EV / Earnings | 99.62 |
| EV / Sales | 2.87 |
| EV / EBITDA | 51.89 |
| EV / EBIT | 68.08 |
| EV / FCF | 73.25 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.41 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.67 |
| Debt / FCF | 0.95 |
| Interest Coverage | 9.94 |
Financial Efficiency
Return on equity (ROE) is 9.68% and return on invested capital (ROIC) is 11.34%.
| Return on Equity (ROE) | 9.68% |
| Return on Assets (ROA) | 5.27% |
| Return on Invested Capital (ROIC) | 11.34% |
| Return on Capital Employed (ROCE) | 12.29% |
| Weighted Average Cost of Capital (WACC) | 5.73% |
| Revenue Per Employee | 1.19M |
| Profits Per Employee | 34,438 |
| Employee Count | 162 |
| Asset Turnover | 2.00 |
| Inventory Turnover | 6.32 |
Taxes
In the past 12 months, Kits Eyecare has paid 2.59 million in taxes.
| Income Tax | 2.59M |
| Effective Tax Rate | 31.73% |
Stock Price Statistics
The stock price has increased by +99.77% in the last 52 weeks. The beta is 0.26, so Kits Eyecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +99.77% |
| 50-Day Moving Average | 19.33 |
| 200-Day Moving Average | 16.23 |
| Relative Strength Index (RSI) | 37.23 |
| Average Volume (20 Days) | 73,838 |
Short Selling Information
The latest short interest is 14,456, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 14,456 |
| Short Previous Month | 16,245 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kits Eyecare had revenue of CAD 193.40 million and earned 5.58 million in profits. Earnings per share was 0.16.
| Revenue | 193.40M |
| Gross Profit | 69.53M |
| Operating Income | 8.16M |
| Pretax Income | 8.17M |
| Net Income | 5.58M |
| EBITDA | 9.72M |
| EBIT | 8.16M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 19.69 million in cash and 7.21 million in debt, with a net cash position of 12.48 million or 0.39 per share.
| Cash & Cash Equivalents | 19.69M |
| Total Debt | 7.21M |
| Net Cash | 12.48M |
| Net Cash Per Share | 0.39 |
| Equity (Book Value) | 62.00M |
| Book Value Per Share | 1.93 |
| Working Capital | 13.16M |
Cash Flow
In the last 12 months, operating cash flow was 8.81 million and capital expenditures -1.23 million, giving a free cash flow of 7.59 million.
| Operating Cash Flow | 8.81M |
| Capital Expenditures | -1.23M |
| Free Cash Flow | 7.59M |
| FCF Per Share | 0.24 |
Margins
Gross margin is 35.95%, with operating and profit margins of 4.22% and 2.88%.
| Gross Margin | 35.95% |
| Operating Margin | 4.22% |
| Pretax Margin | 4.23% |
| Profit Margin | 2.88% |
| EBITDA Margin | 5.03% |
| EBIT Margin | 4.22% |
| FCF Margin | 3.92% |
Dividends & Yields
Kits Eyecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.93% |
| Shareholder Yield | -7.93% |
| Earnings Yield | 0.98% |
| FCF Yield | 1.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kits Eyecare has an Altman Z-Score of 8.23 and a Piotroski F-Score of 7.
| Altman Z-Score | 8.23 |
| Piotroski F-Score | 7 |